molybdenum disulfide has been researched along with Osteoarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, MT; Fan, Y; Ni, J; Shi, J; Wen, C; Yang, M | 1 |
| Chen, X; Liu, J; Liu, Y; Wei, C; Yu, Q; Zhao, Y | 1 |
2 other study(ies) available for molybdenum disulfide and Osteoarthritis
| Article | Year |
|---|---|
Nerve Growth Factor-Targeted Molecular Theranostics Based on Molybdenum Disulfide Nanosheet-Coated Gold Nanorods (MoS
Topics: Animals; Gold; Hyperalgesia; Mice; Molybdenum; Nanotubes; Nerve Growth Factor; Osteoarthritis; Pain; Phototherapy; Precision Medicine; Theranostic Nanomedicine | 2021 |
Drug Delivery System Based on Near-Infrared Light-Responsive Molybdenum Disulfide Nanosheets Controls the High-Efficiency Release of Dexamethasone To Inhibit Inflammation and Treat Osteoarthritis.
Topics: Animals; Dexamethasone; Disulfides; Drug Carriers; Drug Liberation; Infrared Rays; Interleukin-1beta; Joints; Lipopolysaccharides; Macrophages; Mice; Molybdenum; Nanostructures; Osteoarthritis; Phototherapy; RAW 264.7 Cells; Tumor Necrosis Factor-alpha | 2019 |